H.R. 1488 · 118th Congress · Health

Affordable Insulin Now Act

Died in committee1.8k words Introduced Mar 9, 2023 · Latest action Dec 17, 2024

How far it has goneStopped at 2 of 6 · Died in committee
  1. IntroducedMar 9, 2023 Done
  2. CommitteeDied Jan 3, 2025 Stopped here
  3. House floorNot yet Not reached yet
  4. Senate floorNot yet Not reached yet
  5. Chambers agreeNot yet Not reached yet
  6. PresidentNot yet Not reached yet

What it does

This bill limits cost-sharing for insulin under private health insurance.

Specifically, the bill caps cost-sharing under private health insurance for a month's supply of selected insulin products at $35 or 25% of a plan's negotiated price (after any price concessions), whichever is less, beginning in 2024.

Congressional Research Service · summary of “Introduced in House” version · Mar 9, 2023

Who lobbies on it

6 organizations · 31 filings · Q1 2023–Q4 2024

These 6 organizations’ PACs gave $206K to 34 of the 103 members sponsoring or cosponsoring H.R. 1488 in the 2025–26 election cycle.

See who got it, from which PACs, and how they compare to the rest of the House → Pro

One square per quarter since introduction, oldest left. Filled = named it that quarter.

  1. America's Health Insurance Plans Inc (ahip) 8 of 8 quarters
    “…H.R. 1488 - Affordable Insulin Now Act of 2023 - Rep. Craig, Angie - cost-sharing for insulin products H.R. 2666 - MVP Act - Rep. Guthrie, Brett - value-based purchasing arrangements under Medicaid program and reforms to price reporting H.R. 2691 - Transparent Price Act - Rep. McMorris Rodgers, Cathy - health insurer…”

    $11.8M lobbying spend in 2024, all issuesQ4 2024 filing

  2. Highmark Inc 7 of 8 quarters
    “…H.R. 1488/S. 954 - The Affordable Insulin Now Act -- A bill to provide for appropriate cost-sharing for insulin products covered under private health plans, and to establish a program to support health care providers and pharmacies in providing discounted insulin products to uninsured individuals. S. 127. - The…”

    $590K lobbying spend in 2024, all issuesQ3 2024 filing

  3. Eli Lilly and Company 6 of 8 quarters
    “…Affordable Insulin Now Act (S.954/HR.1488), The INSULIN Act; Policy matters related to Artificial Intelligence in health care.”

    $7.9M lobbying spend in 2024, all issuesQ4 2024 filing

3 more organizations, every filingPROUpgrade

Organizations that named H.R. 1488 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. “Gave to” means the organization’s PAC gave to the member’s campaign in the 2025–26 cycle, net of refunds; it doesn’t mean the money was about this bill. Organizations may lobby for, against, or to change a bill; filings don’t say which. Source: Senate lobbying disclosures (LD-2) from lda.gov; PAC gifts from FEC filings; quotes are word for word from the “specific lobbying issues” field; where a filing lists many bills, the quote starts where it names this one.

Actions

4 actions · newest first
  1. Dec 17, 2024Referred to the Subcommittee on Health.
  2. Mar 17, 2023Referred to the Subcommittee on Health.
  3. Mar 9, 2023Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and the Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  4. Mar 9, 2023Introduced in House